文献速递脑血管病

CASCOM研究:CAR评分预测症状性颈动脉狭窄强化药物治疗后复发卒中

CASCOM Study: CAR Score Predicting Restroke in Symptomatic Carotid Stenosis With Only Intensive Medical Therapy.
PubMed 文献 · Stroke · 2025-08-07

这项前瞻性单臂观察性研究纳入109例近期TIA、一过性黑矇或小卒中且同侧症状性颈动脉狭窄50%-99%的患者,均接受强化药物治疗。2年内同侧复发卒中或死亡率为5.5%,CAR评分≤20%者2年卒中率3.1%,显著低于CAR评分>20%者的23%(P=0.02)。

要点

  • 强化药物治疗下症状性颈动脉狭窄2年同侧复发卒中率仅5.5%。
  • CAR评分≤20%者2年卒中率3.1%,显著低于>20%者的23%。
  • CAR评分≤20%亚组预测准确性高,阳性预测值0.97。

核心结论

  • 强化药物治疗与症状性颈动脉狭窄患者低复发卒中率相关。
  • CAR评分≤20%的患者复发卒中风险极低,提示部分患者可保守治疗。

研究设计与样本

  • 前瞻性单臂观察性研究,丹麦2020年10月至2023年3月,纳入109例近期TIA、一过性黑矇或小卒中且同侧症状性颈动脉狭窄50%-99%的患者。
  • 所有患者接受强化药物治疗,主要结局为2年内同侧复发卒中或死亡。

主要发现

  • 平均年龄73岁,男性占60%。
  • 6例(5.5%)发生同侧复发卒中,较历史NASCET率(约23%)降低约75%。
  • CAR评分≤20%组(n=96)2年卒中率3.1%,显著低于CAR评分>20%组(n=13)的23%(P=0.02)。
  • CAR评分≤20%亚组敏感性0.90,特异性0.50,阳性预测值0.97。

临床怎么用

  • CAR评分可用于识别症状性颈动脉狭窄中复发卒中风险极低、可能适合保守治疗的患者。
  • 强化药物治疗下,CAR评分≤20%的患者2年卒中风险很低,支持个体化治疗决策。

局限性

  • 单臂观察性研究,无随机对照,样本量较小(109例)。
  • CAR评分>20%亚组仅13例,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid endarterectomy for symptomatic carotid stenosis is based on decades-old trials, while modern medical therapy has substantially improved outcomes. The carotid artery risk (CAR) score predicts stroke risk using clinical and imaging factors. This study evaluates the 2-year risk of recurrent ipsilateral stroke in patients with recent transient ischemic attack, amaurosis fugax, or minor stroke and ipsilateral symptomatic carotid stenosis treated with intensive medical therapy. METHODS: In this prospective, single-arm observational study conducted in Denmark from October 2020 to March 2023, we enrolled 109 patients with recent TIA, amaurosis fugax, or minor stroke and 50% to 99% ipsilateral symptomatic carotid stenosis. Patients with a CAR score ≤20% or >20%, as well as those with contraindications to surgery, were included. All received intensive medical therapy. The primary outcome was ipsilateral recurrent stroke or death within 2 years. RESULTS: The mean age was 73 years; 60% were male patients. Six patients (5.5%) experienced ipsilateral recurrent stroke, representing a ≈75% reduction compared with historical NASCET (North American Symptomatic Carotid Endarterectomy Trial) rates (≈23%). Patients with CAR score ≤20% (n=96) had a significantly lower 2-year stroke rate (3.1%) than those with CAR score >20% (n=13; 23%; P=0.02). The CAR score ≤20% subgroup showed high predictive accuracy: sensitivity of 0.90, specificity of 0.50, and positive predictive value of 0.97. CONCLUSIONS: In this observational study, modern medical therapy was associated with low rates of recurrent stroke in patients with symptomatic carotid stenosis. Patients with a CAR score ≤20% had a very low risk of recurrent stroke, suggesting that selected patients may be managed conservatively.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Shahidi S, Wienecke T, Noeddeskov Eilersen E, et al. CASCOM Study: CAR Score Predicting Restroke in Symptomatic Carotid Stenosis With Only Intensive Medical Therapy. Stroke. 2025. PMID: 40772324. doi:10.1161/STROKEAHA.125.052151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。